Zhuhai Hejia Medical Equipment Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
Zhuhai Hejia Medical Equipment Co., Ltd. (hereinafter referred to as "the Company") received an audit report from Asia-Pacific (Group) CPA Firm (Special General Partnership) (hereinafter referred to as "Asia-Pacific CPA Firm") for the 2021 financial accounting report, which expressed an inability to issue an opinion. According to the relevant provisions of the "Shenzhen Stock Exchange GEM Stock Listing Rules" (hereinafter referred to as "the Listing Rules"), the Company's stock has been subject to delisting risk warning since May 5, 2022. Based on the Company's "2022 Annual Report" and "2022 Annual Audit Report" disclosed on April 29, 2023, the Asia-Pacific CPA Firm also issued an inability to express an opinion audit report for the Company's 2022 financial accounting report. The Company will be delisted due to the triggering of Article 10.3.10, Paragraph 1, Item (3) of the Listing Rules, which states that "an audit report with a qualified opinion, inability to express an opinion, or adverse opinion on the financial accounting report" leads to delisting. On May 4, 2023, the Company received a "Pre-Notice" from the Shenzhen Stock Exchange (hereinafter referred to as "SZSE"), indicating that it intends to terminate the Company's stock listing. For specific details, please refer to the Company's announcement titled "Notice of Receipt of Pre-Notice of Termination of Stock Listing from Shenzhen Stock Exchange and Risk Warning of Possible Termination of Company's Stock Listing" (Announcement No.: 2023-057). Investors are advised to pay attention to investment risks.